Activation mechanism of endothelin ETB receptor by endothelin-1

被引:0
作者
Wataru Shihoya
Tomohiro Nishizawa
Akiko Okuta
Kazutoshi Tani
Naoshi Dohmae
Yoshinori Fujiyoshi
Osamu Nureki
Tomoko Doi
机构
[1] Graduate School of Pharmaceutical Sciences,Department of Basic Medicinal Sciences
[2] Nagoya University,Department of Biophysics and Biochemistry
[3] Cellular and Structural Physiology Institute,Department of Biophysics
[4] Nagoya University,undefined
[5] Graduate School of Science,undefined
[6] The University of Tokyo,undefined
[7] Precursory Research for Embryonic Science and Technology (PRESTO),undefined
[8] Japan Science and Technology Agency,undefined
[9] 4-1-8 Honcho,undefined
[10] Biomolecular Characterization Unit,undefined
[11] RIKEN Center for Sustainable Resource Science,undefined
[12] Graduate School of Science,undefined
[13] Kyoto University,undefined
来源
Nature | 2016年 / 537卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Endothelin, a 21-amino-acid peptide, participates in various physiological processes, such as regulation of vascular tone, humoral homeostasis, neural crest cell development and neurotransmission. Endothelin and its G-protein-coupled receptor are involved in the development of various diseases, such as pulmonary arterial hypertension, and thus are important therapeutic targets. Here we report crystal structures of human endothelin type B receptor in the ligand-free form and in complex with the endogenous agonist endothelin-1. The structures and mutation analysis reveal the mechanism for the isopeptide selectivity between endothelin-1 and -3. Transmembrane helices 1, 2, 6 and 7 move and envelop the entire endothelin peptide, in a virtually irreversible manner. The agonist-induced conformational changes are propagated to the receptor core and the cytoplasmic G-protein coupling interface, and probably induce conformational flexibility in TM6. A comparison with the M2 muscarinic receptor suggests a shared mechanism for signal transduction in class A G-protein-coupled receptors.
引用
收藏
页码:363 / 368
页数:5
相关论文
共 139 条
[1]  
Yanagisawa M(1988)A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 411-415
[2]  
Barton M(2008)Endothelin: 20 years from discovery to therapy Can. J. Physiol. Pharmacol. 86 485-498
[3]  
Yanagisawa M(2001)Endothelin system: the double-edged sword in health and disease Annu. Rev. Pharmacol. Toxicol. 41 851-876
[4]  
Kedzierski RM(2011)Regulation of blood pressure and salt homeostasis by endothelin Physiol. Rev. 91 1-77
[5]  
Yanagisawa M(1994)Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology Pharmacol. Rev. 46 325-415
[6]  
Kohan DE(1996)Interaction of endothelin-1 with cloned bovine ETA receptors: biochemical parameters and functional consequences Biochemistry 35 14868-14875
[7]  
Rossi NF(2009)Endothelin-1, an endogenous irreversible agonist in search of an allosteric inhibitor Mol. Cell. Pharmacol. 1 246-257
[8]  
Inscho EW(1994)Human endothelin receptor ET J. Biol. Chem. 269 7509-7513
[9]  
Pollock DM(1997). Amino acid sequence requirements for super stable complex formation with its ligand J. Pharmacol. Exp. Ther. 281 267-273
[10]  
Rubanyi GM(1999)The quasi-irreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes Biochemistry 38 3090-3099